Ageing

Continuous Renal Replacement Therapy (CRRT) - Global Market Trajectory & Analytics to 2026 - ResearchAndMarkets.com

Retrieved on: 
Thursday, August 18, 2022 - 10:22am

The "Continuous Renal Replacement Therapy (CRRT) - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Continuous Renal Replacement Therapy (CRRT) - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • The United States represents the largest regional market for Continuous Renal Replacement Therapy (CRRT), and is projected to reach US$422.4 Million by 2026.
  • The global Continuous Renal Replacement Therapy (CRRT) market is expected to increase rapidly in future, driven by rising incidence of acute kidney injury (AKI).
  • Europe and the United States dominate the Continuous Renal Replacement Therapy market, driven by the fast growing aging population and increasing acute kidney injury cases.

Valneva Provides Update on IXIARO® Supply Contract with U.S. Department of Defense

Retrieved on: 
Thursday, August 18, 2022 - 6:00am

Due to the past and ongoing impact of the COVID-19 pandemic on its operations, the DoD considers its existing IXIARO supply levels sufficient to meet current needs.

Key Points: 
  • Due to the past and ongoing impact of the COVID-19 pandemic on its operations, the DoD considers its existing IXIARO supply levels sufficient to meet current needs.
  • The DoD has communicated an interest in negotiating a new supply contract in 2023, once inventory returns to standard levels.
  • The DoD has relied on IXIARO since 2010 to help protect personnel who are deployed to JE endemic areas, for whom JE vaccination is recommended.
  • Thomas Lingelbach, President and Chief Executive Officer of Valneva, commented: We thank the DoD for their partnership and look forward to further contract negotiations in the future.

UNITY Biotechnology Announces Pricing of Upsized Underwritten Public Offering

Retrieved on: 
Thursday, August 18, 2022 - 4:04am

SOUTH SAN FRANCISCO, Calif., Aug. 17, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) (Nasdaq:UBX), a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced the pricing of an upsized underwritten public offering of 64,285,714 shares of its common stock and accompanying warrants to purchase up to 64,285,714 shares of common stock at a combined public offering price of $0.70 per share and accompanying warrant.

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., Aug. 17, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) (Nasdaq:UBX), a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced the pricing of an upsized underwritten public offering of 64,285,714 shares of its common stock and accompanying warrants to purchase up to 64,285,714 shares of common stock at a combined public offering price of $0.70 per share and accompanying warrant.
  • The gross proceeds to UNITY from the offering are expected to be approximately $45.0 million, before underwriting discounts and commissions and offering costs.
  • The offering is expected to close on August 22, 2022, subject to customary closing conditions.
  • These statements are based on UNITYs current beliefs and expectations and include the UNITYs statements regarding the completion of its offering.

InnovAge Names Richard Feifer, MD, MPH, as Chief Medical Officer

Retrieved on: 
Wednesday, August 17, 2022 - 9:05pm

InnovAge President and Chief Executive Officer Patrick Blair said, There is nothing more important than ensuring we are consistently delivering outstanding care for our participants.

Key Points: 
  • InnovAge President and Chief Executive Officer Patrick Blair said, There is nothing more important than ensuring we are consistently delivering outstanding care for our participants.
  • As CMO, Feifer will lead InnovAges clinical care delivery, including medical care, quality, pharmacy, dental, and behavioral health.
  • As executive vice president and chief medical officer, he oversaw one of the nation's largest skilled nursing and long-term care providers, operating nearly 400 facilities in 26 states in 2019.
  • Also with Genesis HealthCare, Feifer launched and served as chief medical officer for the only national accountable care organization focused on nursing home residents, LTC ACO.

Harpak-ULMA Selected to Support Federal Pipette Tip Production Contract

Retrieved on: 
Wednesday, August 17, 2022 - 8:36pm

Harpak-ULMA, the industry leader in smart, connected packaging solutions, has been selected by a major medical device producer to provide automated flow wrap packaging lines for pipette tip production.

Key Points: 
  • Harpak-ULMA, the industry leader in smart, connected packaging solutions, has been selected by a major medical device producer to provide automated flow wrap packaging lines for pipette tip production.
  • The move will ensure reliable, US-based production of a vital tool utilized to dispense precise amounts of liquid in disease research and diagnostic labs.
  • View the full release here: https://www.businesswire.com/news/home/20220817005577/en/
    Harpak-ULMA end-to-end packaging solutions incorporate product loading, primary, secondary, and tertiary packaging capabilities.
  • The companys solutions will meet or exceed the high levels of scalability, medical device packaging quality, and overall throughput demanded at extreme production levels.

USPTO Grants Xenocor Fourth US Patent, Achieving Increased Protection for their Novel Saberscope System

Retrieved on: 
Wednesday, August 17, 2022 - 7:34pm

SALT LAKE CITY, Aug. 17, 2022 /PRNewswire/ -- Xenocor, a Utah-based medical device company, today announced newly issued U.S. patent protection for the Saberscope system from the United States Patent and Trademark Office (USPTO).

Key Points: 
  • SALT LAKE CITY, Aug. 17, 2022 /PRNewswire/ -- Xenocor, a Utah-based medical device company, today announced newly issued U.S. patent protection for the Saberscope system from the United States Patent and Trademark Office (USPTO).
  • The Saberscope system is the world's first true HD, fog free, omnidirectional articulating, recyclable laparoscope.
  • "The Saberscope system is the world's first true HD, fog free, omnidirectional articulating, recyclable laparoscope."
  • Xenocor is a privately held company that designs, develops, and commercializes medical devices including the Saberscope system.

U.S. Concierge Medicine Market to Reach $13.3 Billion by 2030 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, August 17, 2022 - 5:21pm

The "U.S. Concierge Medicine Market Size, Share & Trends Analysis Report by Application (Primary Care, Internal Medicine, Cardiology, Psychiatry), by Ownership (Standalone, Group), and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "U.S. Concierge Medicine Market Size, Share & Trends Analysis Report by Application (Primary Care, Internal Medicine, Cardiology, Psychiatry), by Ownership (Standalone, Group), and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.
  • The U.S. concierge medicine market size is expected to reach USD 13.3 billion by 2030.
  • The market is expected to expand at a CAGR of 10.27% over the forecast period.
  • This, coupled with more time with physicians, fewer hospitalizations, and focus on preventive care are driving the growth of the market.

Amtrak Seeks to Fill Over 4,000 New Roles

Retrieved on: 
Wednesday, August 17, 2022 - 5:30pm

ET

Key Points: 
  • ET
    At Amtrak, the starting pay rate for all onboard service crafts is $21.00 per hour.
  • On the mechanical side, journeyman electricians start at $34.07 per hour and Amtrak offers hiring bonuses and relocation packages to fill critical positions.
  • As Amtrak expands its workforce, the company remains committed to fostering an environment where diverse ideas, backgrounds and perspectives thrive.
  • To stay up to date on career opportunities and upcoming hiring events, please visit the Amtrak career site at careers.Amtrak.com .

UVeye and Tekion Partner to Enhance the Dealership Customer-Service Experience

Retrieved on: 
Wednesday, August 17, 2022 - 5:00pm

The reports are designed to provide clarity and enhance the customer-service experience by helping users decide on the best service solutions possible.

Key Points: 
  • The reports are designed to provide clarity and enhance the customer-service experience by helping users decide on the best service solutions possible.
  • Customers simply can drive through UVeye scanning units at the entrance of the dealership service department.
  • "We're incredibly excited to be collaborating with Tekion to provide an extraordinary experience for dealership customers across the country in the coming months," notes Hever.
  • "We look forward to working with UVeye to deliver a seamless and superior experience to consumers during their vehicle service experience," says Jay Vijayan, CEO and founder of Tekion.

At 20.80% CAGR, Healthcare Mobility Solutions Market Size to Hit USD 130.82 Billion, Globally by 2028 | Industry Trends, Share, Growth Rate, Value, Analysis & Forecast Report By Zion Market Research

Retrieved on: 
Wednesday, August 17, 2022 - 4:00pm

One of the main reasons propelling the growth of the global healthcare mobility solutions market is the increased use of smartphones among the general population.

Key Points: 
  • One of the main reasons propelling the growth of the global healthcare mobility solutions market is the increased use of smartphones among the general population.
  • In addition, the market for healthcare mobility solutions is expanding as a result of an increased emphasis on patient-centric mobility applications and greater utilization of cutting-edge connections to enhance the caliber of healthcare solutions.
  • Global Healthcare Mobility Solutions Market: Challenges
    Breaching of data is proving to be a major hurdle for the healthcare mobility solution market.
  • Global Healthcare Mobility Solutions Market: Segmentation
    The global healthcare mobility solutions market is segmented into products & services, applications, end-user, and region.